[Federal Register Volume 63, Number 152 (Friday, August 7, 1998)] [Notices] [Pages 42404-42405] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-21088] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 98N-0515] Agency Information Collection Activities; Submission for OMB Review; Comment Request AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA). DATES: Submit written comments on the collection of information by September 8, 1998. ADDRESSES: Submit written comments on the collection of information to the Office of Information and Regulatory Affairs, OMB, New Executive Office Bldg., 725 17th St. NW., rm. 10235, Washington, DC 20503, Attn: Desk Officer for FDA. FOR FURTHER INFORMATION CONTACT: Margaret R. Schlosburg, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223. SUPPLEMENTARY INFORMATION: In compliance with section 3507 of the PRA (44 U.S.C. 3507), FDA has submitted the following proposed collection of information to OMB for review and clearance. Amendments to Humanitarian Use Device (HUD) Requirements Section 520(m) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360j(f)) was created as an incentive for the development of HUD's for use in the treatment or diagnosis of diseases or conditions affecting fewer than 4,000 individuals in the United States. FDA is issuing this rule to amend the existing regulations governing HUD's, found in part 814 (21 CFR part 814), to conform to the amendments made by the Food and Drug Administration Modernization Act of 1997 (FDAMA) to section 520(m) of the act. In the Federal Register of April 17, 1998 (63 FR 19185), the agency requested comments on the proposed collection of information amending the regulations governing HUD's. FDA received one comment concerning the information collection provisions of the rule. A summary of the comment and FDA's response is provided as follows. The comment objected to the annual reporting requirement and suggested that FDA determine the appropriate reporting period at the time of product approval rather than always requiring reporting on an annual basis. FDA has modified the rule in response to this comment. Under the final rule of June 26, 1996 (61 FR 33232), a humanitarian device exemption (HDE) holder was required to obtain approval of an extension request every 18 months in order to continue marketing the HUD. FDAMA eliminated this requirement but provided that FDA may require the holder to demonstrate continued compliance with the HDE requirements if the agency believes that such demonstration is needed to protect the public health or has reason to believe that the criteria for the exemption are no longer met. FDA included a provision for annual reporting in the proposed rule because the agency believed that annual reporting would be the most appropriate mechanism for the agency to monitor whether there is reason to question the continued exemption of the device from the act's effectiveness requirements. Upon reconsideration, FDA has determined that the reporting frequency necessary to protect the public health may vary depending upon the device, its intended use, the affected patient population, and experience with the device after it is marketed. Therefore, Sec. 814.126(b)(1) has been modified in the final rule to state that the frequency of the reports will be specified in the approval order for the HDE. Ordinarily, FDA does not expect to require periodic reports to be submitted more frequently than annually. FDA does believe, however, that it may be appropriate to require reports on certain HDE's less frequently and that in many cases the frequency of required reports will decrease after the device has been marketed for a period of time. FDA estimates that, due to the nature of some of the devices, initially 15 HDE holders per year will be required to submit annual reports. As the agency and industry gain experience with HDE's, FDA believes the number of HDE holders who will be required to submit annual reports will decrease. FDA believes that much of the information will already be in the HDE holder's possession, and the agency estimates that the reports will take an average of 120 hours per response. The same comment also objected to the ``requirement'' that an ``HDE holder maintain records in perpetuity * * *'' and suggested that a more appropriate timeframe would be 3-calendar years after the manufacturer ceases distribution of the product in question. Section 814.126(b)(2) of the HDE regulation specifies the types of records that should be maintained by the HDE holder, but does not specify the [[Page 42405]] timeframe for maintaining such records. FDA agrees that a reasonable timeframe should be established for maintaining such records and intends to specify such timeframes as part of the approval order. Accordingly, FDA has modified the regulation to state that records shall be maintained in accordance with the approval order for the HDE. Section 814.124(a) is amended to allow physicians in emergency situations to administer a HUD prior to obtaining institutional review board (IRB) approval. In such situations, the physician is required to provide written notification, including the identification of the patient involved, the date of use, and the reason for use, to the IRB within 5 days after emergency use. FDA anticipates that five physicians will use HUD's in emergency situations before obtaining approval from an IRB. FDA estimates that notifications under this section will take an average of 1 hour per response. In addition to the changes required by FDAMA, FDA is amending Sec. 814.104(b)(5) to allow a sponsor who is charging more than $250 per HUD to submit, in lieu of a report by an independent CPA, an attestation by a responsible individual of the organization, verifying that the amount charged does not exceed the device's cost of research, development, fabrication, and distribution. In addition, the amendments to Sec. 814.104(b)(5) waive the requirement for submission of any CPA report or attestation for HUD's for which an HDE applicant is charging $250 or less. FDA anticipates, based on past experience, that 7 of the anticipated 15 HDE holders per year will charge less than $250 per HUD, and thus be exempt from the Sec. 814.104(b)(5) requirement altogether. For the remaining eight HDE holders, FDA anticipates that all will submit attestations in lieu of CPA reports, and estimates that these submissions will require 2 hours to complete. Description of Respondents: Business or other for profit organizations. FDA estimates the burden for this collection of information as follows: Table 1.--Estimated Annual Reporting Burden1 ---------------------------------------------------------------------------------------------------------------- Annual 21 CFR Section No. of Frequency per Total Annual Hours per Total Hours Respondents Response Responses Response ---------------------------------------------------------------------------------------------------------------- 814.104(b)(5) 8 1 8 2 16 814.124(a) 5 1 5 1 5 814.126(b)(1) 15 1 15 120 1,800 Total 1,821 ---------------------------------------------------------------------------------------------------------------- \1\ There are no operating and maintenance costs or capital costs associated with this collection of information. Table 2.--Estimated Annual Recordkeeping Burden1 ---------------------------------------------------------------------------------------------------------------- Annual 21 CFR Section No. of Frequency per Total Annual Hours per Total Hours Recordkeepers Recordkeeping Records Recordkeeper ---------------------------------------------------------------------------------------------------------------- 814.126(b)(2) 15 1 15 2 30 ---------------------------------------------------------------------------------------------------------------- \1\ There are no operating and maintenance costs or capital costs associated with this collection of information. Dated: July 31, 1998. William K. Hubbard, Associate Commissioner for Policy Coordination. [FR Doc. 98-21088 Filed 8-6-98; 8:45 am] BILLING CODE 4160-01-F